Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis

Human amniotic fluid stem cells have become an attractive stem cell source for potential applications in regenerative medicine and tissue engineering. The aim of this study was to characterize amniotic fluid-derived mesenchymal stem cells (AF-MSCs) from second- and third-trimester of gestation. Usin...

Full description

Saved in:
Bibliographic Details
Main Authors: Jurate Savickiene, Grazina Treigyte, Sandra Baronaite, Giedre Valiuliene, Algirdas Kaupinis, Mindaugas Valius, Audrone Arlauskiene, Ruta Navakauskiene
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2015/319238
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549502028873728
author Jurate Savickiene
Grazina Treigyte
Sandra Baronaite
Giedre Valiuliene
Algirdas Kaupinis
Mindaugas Valius
Audrone Arlauskiene
Ruta Navakauskiene
author_facet Jurate Savickiene
Grazina Treigyte
Sandra Baronaite
Giedre Valiuliene
Algirdas Kaupinis
Mindaugas Valius
Audrone Arlauskiene
Ruta Navakauskiene
author_sort Jurate Savickiene
collection DOAJ
description Human amniotic fluid stem cells have become an attractive stem cell source for potential applications in regenerative medicine and tissue engineering. The aim of this study was to characterize amniotic fluid-derived mesenchymal stem cells (AF-MSCs) from second- and third-trimester of gestation. Using two-stage protocol, MSCs were successfully cultured and exhibited typical stem cell morphological, specific cell surface, and pluripotency markers characteristics. AF-MSCs differentiated into adipocytes, osteocytes, chondrocytes, myocytes, and neuronal cells, as determined by morphological changes, cell staining, and RT-qPCR showing the tissue-specific gene presence for differentiated cell lineages. Using SYNAPT G2 High Definition Mass Spectrometry technique approach, we performed for the first time the comparative proteomic analysis between undifferentiated AF-MSCs from late trimester of gestation and differentiated into myogenic, adipogenic, osteogenic, and neurogenic lineages. The analysis of the functional and expression patterns of 250 high abundance proteins selected from more than 1400 demonstrated the similar proteome of cultured and differentiated AF-MSCs but the unique changes in their expression profile during cell differentiation that may help the identification of key markers in differentiated cells. Our results provide evidence that human amniotic fluid of second- and third-trimester contains stem cells with multilineage potential and may be attractive source for clinical applications.
format Article
id doaj-art-481537ba80724eb3ba0e0eeaacee246f
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-481537ba80724eb3ba0e0eeaacee246f2025-02-03T06:11:10ZengWileyStem Cells International1687-966X1687-96782015-01-01201510.1155/2015/319238319238Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome AnalysisJurate Savickiene0Grazina Treigyte1Sandra Baronaite2Giedre Valiuliene3Algirdas Kaupinis4Mindaugas Valius5Audrone Arlauskiene6Ruta Navakauskiene7Department of Molecular Cell Biology, Vilnius University, LT-08662 Vilnius, LithuaniaDepartment of Molecular Cell Biology, Vilnius University, LT-08662 Vilnius, LithuaniaDepartment of Molecular Cell Biology, Vilnius University, LT-08662 Vilnius, LithuaniaDepartment of Molecular Cell Biology, Vilnius University, LT-08662 Vilnius, LithuaniaProteomic Center, Institute of Biochemistry, Vilnius University, LT-08662 Vilnius, LithuaniaProteomic Center, Institute of Biochemistry, Vilnius University, LT-08662 Vilnius, LithuaniaClinics of Obstetrics and Gynecology, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Gatvė 21, LT-03101 Vilnius, LithuaniaDepartment of Molecular Cell Biology, Vilnius University, LT-08662 Vilnius, LithuaniaHuman amniotic fluid stem cells have become an attractive stem cell source for potential applications in regenerative medicine and tissue engineering. The aim of this study was to characterize amniotic fluid-derived mesenchymal stem cells (AF-MSCs) from second- and third-trimester of gestation. Using two-stage protocol, MSCs were successfully cultured and exhibited typical stem cell morphological, specific cell surface, and pluripotency markers characteristics. AF-MSCs differentiated into adipocytes, osteocytes, chondrocytes, myocytes, and neuronal cells, as determined by morphological changes, cell staining, and RT-qPCR showing the tissue-specific gene presence for differentiated cell lineages. Using SYNAPT G2 High Definition Mass Spectrometry technique approach, we performed for the first time the comparative proteomic analysis between undifferentiated AF-MSCs from late trimester of gestation and differentiated into myogenic, adipogenic, osteogenic, and neurogenic lineages. The analysis of the functional and expression patterns of 250 high abundance proteins selected from more than 1400 demonstrated the similar proteome of cultured and differentiated AF-MSCs but the unique changes in their expression profile during cell differentiation that may help the identification of key markers in differentiated cells. Our results provide evidence that human amniotic fluid of second- and third-trimester contains stem cells with multilineage potential and may be attractive source for clinical applications.http://dx.doi.org/10.1155/2015/319238
spellingShingle Jurate Savickiene
Grazina Treigyte
Sandra Baronaite
Giedre Valiuliene
Algirdas Kaupinis
Mindaugas Valius
Audrone Arlauskiene
Ruta Navakauskiene
Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis
Stem Cells International
title Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis
title_full Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis
title_fullStr Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis
title_full_unstemmed Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis
title_short Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis
title_sort human amniotic fluid mesenchymal stem cells from second and third trimester amniocentesis differentiation potential molecular signature and proteome analysis
url http://dx.doi.org/10.1155/2015/319238
work_keys_str_mv AT juratesavickiene humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis
AT grazinatreigyte humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis
AT sandrabaronaite humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis
AT giedrevaliuliene humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis
AT algirdaskaupinis humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis
AT mindaugasvalius humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis
AT audronearlauskiene humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis
AT rutanavakauskiene humanamnioticfluidmesenchymalstemcellsfromsecondandthirdtrimesteramniocentesisdifferentiationpotentialmolecularsignatureandproteomeanalysis